Cargando…

Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation

The ongoing coronavirus disease-19 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has drastically changed our way of life and continues to have an unmitigated socioeconomic impact across the globe. Research into potential vaccine design and production is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Tingting, Li, Tingting, Chen, Gege, Zhu, Yuhe, Xu, Lang, Lin, Yanlin, Sun, Hui, Zhang, Hui, Fang, Qianjiao, Hong, Junping, Wu, Dinghui, Gao, Shuangquan, Li, Shaoyong, Wang, Yingbin, Zhang, Tianying, Chen, Yixin, Yuan, Quan, Zheng, Qingbing, Yu, Hai, Zhao, Qinjian, Zhang, Jun, Li, Shaowei, Xia, Ningshao, Gu, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510068/ https://www.ncbi.nlm.nih.gov/pubmed/36253220 http://dx.doi.org/10.1016/j.vaccine.2022.09.057

Ejemplares similares

SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates
por: Li, Tingting, et al.
Publicado: (2020)

A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice
por: Liu, Liqin, et al.
Publicado: (2022)

T = 4 Icosahedral HIV-1 Capsid As an Immunogenic Vector for HIV-1 V3 Loop Epitope Display
por: Zhang, Zhiqing, et al.
Publicado: (2018)

Current progress and challenges in the design and development of a successful COVID-19 vaccine
por: Li, Tingting, et al.
Publicado: (2021)

A stepwise docking molecular dynamics approach for simulating antibody recognition with substantial conformational changes
por: Huang, Yang, et al.
Publicado: (2022)

Truncated glycoprotein E of varicella-zoster virus is an ideal immunogen for Escherichia coli-based vaccine design
por: Chen, Tingting, et al.
Publicado: (2023)

Omics-guided bacterial engineering of Escherichia coli ER2566 for recombinant protein expression
por: Zhou, Lizhi, et al.
Publicado: (2022)

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants
por: Li, Tingting, et al.
Publicado: (2021)

Construction of a bacterial surface display system based on outer membrane protein F
por: Chen, Tingting, et al.
Publicado: (2019)

Engineering for an HPV 9-valent vaccine candidate using genomic constitutive over-expression and low lipopolysaccharide levels in Escherichia coli cells
por: Wang, Kaihang, et al.
Publicado: (2021)

Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective
por: Huang, Yang, et al.
Publicado: (2020)

Viral neutralization by antibody-imposed physical disruption
por: Zheng, Qingbing, et al.
Publicado: (2019)

Structural Basis for the Shared Neutralization Mechanism of Three Classes of Human Papillomavirus Type 58 Antibodies with Disparate Modes of Binding
por: He, Maozhou, et al.
Publicado: (2021)

Baculovirus Display of Varicella–Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice
por: Xue, Wenhui, et al.
Publicado: (2022)

Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection
por: Liu, Xinlin, et al.
Publicado: (2019)

Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles
por: Wang, Daning, et al.
Publicado: (2020)

Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation
por: Li, Yike, et al.
Publicado: (2020)

The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
por: Xiong, Hualong, et al.
Publicado: (2022)

Genome re-sequencing and reannotation of the Escherichia coli ER2566 strain and transcriptome sequencing under overexpression conditions
por: Zhou, Lizhi, et al.
Publicado: (2020)

Recent Progress on the Versatility of Virus-Like Particles
por: Qian, Ciying, et al.
Publicado: (2020)

Influence of N-glycosylation in the A and C domains on the immunogenicity of factor VIII
por: Vander Kooi, Amber, et al.
Publicado: (2022)

Immune escape by SARS-CoV-2 Omicron variant and structural basis of its effective neutralization by a broad neutralizing human antibody VacW-209
por: Ju, Bin, et al.
Publicado: (2022)

Antibody Generation and Immunogenicity Analysis of EBV gp42 N-Terminal Region
por: Hong, Junping, et al.
Publicado: (2021)

Structures of pseudorabies virus capsids
por: Wang, Guosong, et al.
Publicado: (2022)

Current progress in the development of prophylactic and therapeutic vaccines
por: Li, Tingting, et al.
Publicado: (2022)

Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes
por: Wu, Qian, et al.
Publicado: (2023)

Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70
por: Qian, Ciying, et al.
Publicado: (2022)

Structure and proposed DNA delivery mechanism of a marine roseophage
por: Huang, Yang, et al.
Publicado: (2023)

Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses
por: Li, Tingting, et al.
Publicado: (2022)

Rabbit Monoclonal Antibody Specifically Recognizing a Linear Epitope in the RBD of SARS-CoV-2 Spike Protein
por: Hong, Junping, et al.
Publicado: (2021)

Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron
por: Wang, Siling, et al.
Publicado: (2022)

A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters
por: Wu, Yangtao, et al.
Publicado: (2021)

Nanobody-based sandwich reporter system for living cell sensing influenza A virus infection
por: Cao, Jiali, et al.
Publicado: (2019)

A Secreted Form of the Hepatitis E Virus ORF2 Protein: Design Strategy, Antigenicity and Immunogenicity
por: Chen, Zihao, et al.
Publicado: (2022)

Peptide adjacent to glycosylation sites impacts immunogenicity of glycoconjugate vaccine
por: Ma, Zhongrui, et al.
Publicado: (2017)

Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity
por: Li, Zhihai, et al.
Publicado: (2018)

Structural characterization of a neutralizing mAb H16.001, a potent candidate for a common potency assay for various HPV16 VLPs
por: Huang, Weijin, et al.
Publicado: (2020)

Capsid destabilization and epitope alterations of human papillomavirus 18 in the presence of thimerosal
por: Huang, Xiaofen, et al.
Publicado: (2021)

Genetic engineering of baculovirus-insect cell system to improve protein production
por: Hong, Minqing, et al.
Publicado: (2022)

An optimized secretory expression system and immunogenicity evaluation for glycosylated gp90 of avian reticuloendotheliosis virus
por: Pan, Qing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ctqgrjb7kq8ks3q0e45mn0kjo8